Pipeline Therapeutics, Inc.

For profit

Also known as: Chief Medical Officer, Pipeline Therapeutics, Inc | Chief Medical Officer, Pipeline Therapeutics, Inc. | Pipeline Therapeutics, Inc. | Stemline Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 15, 2020

Last known activity

Mar 31, 2026

Timeline

2010s

Jun 1, 2017
Pipeline Therapeutics, Inc.— Founded

Drugs by trial phase (25 distinct, 24 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (14 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (29)

NCT07198724CollaboratorPhase 1/Phase 2Mar 31, 2026
NCT07148180CollaboratorPhase 1/Phase 2Feb 28, 2026
NCT07222215CollaboratorPhase 2Dec 31, 2025
NCT07007052CollaboratorPhase 2Dec 1, 2025
NCT07226427Lead sponsorPhase 1Nov 30, 2025
NCT07226427OfficialPhase 1Nov 30, 2025
NCT06923527CollaboratorPhase 2Sep 30, 2025
NCT06561152CollaboratorPhase 1/Phase 2Jan 31, 2025
NCT06456463Lead sponsorPhase 2Nov 30, 2024
NCT06201234CollaboratorPhase 2Nov 30, 2024
NCT06638307Lead sponsorPhase 1Oct 31, 2024
NCT06492616OfficialPhase 3Sep 27, 2024
NCT06492616Lead sponsorPhase 3Sep 27, 2024
NCT06382948CollaboratorPhase 3Sep 1, 2024
NCT05720988CollaboratorPhase 1Aug 3, 2024

Details

Founded: San Diego, CA, US Jun 1, 2017
Last known activity: Mar 31, 2026